Safety of Parecoxib in Asthmatic Patients with Aspirin-Exacerbated Respiratory Disease
BACKGROUND Aspirin-exacerbated respiratory disease (AERD) affects a subset of patients with asthma. Cyclooxygenase 2 inhibitors are a safe alternative in patients with AERD. Parecoxib is the first cyclooxygenase 2 selective drug for parenteral administration, especially useful after surgery thanks t...
- Autores:
-
Valero, Antonio
Picado, Cesar
Roca, Jordi
Muñoz-Cano, Rosa
Serrano Reyes, Carlos Daniel
Bartra, Joan
Sánchez López, Jaime
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2011
- Institución:
- Universidad ICESI
- Repositorio:
- Repositorio ICESI
- Idioma:
- eng
- OAI Identifier:
- oai:repository.icesi.edu.co:10906/81246
- Acceso en línea:
- http://www.ncbi.nlm.nih.gov/pubmed/21597303
http://www.karger.com/doi/10.1159/000322841
http://hdl.handle.net/10906/81246
http://dx.doi.org/10.1159/000322841
- Palabra clave:
- Enfermedades respiratorias
Asma - Tratamiento
Ciencias socio biomédicas
Alergia Respiratoria
Medical sciences
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by-nc-nd/4.0/